HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on AnaptysBio (NASDAQ: ANAB) and has maintained a price target of $95 for the stock.